Founded
Address
Domain Associates LLC
12481 High Bluff Drive
Suite 150
San Diego, CA 92130
United States
Phone
Email
Website
Recent investment activity
KANDO id: 31340
Company type
Venture capital firm focused on life sciences companies.Funding rounds
Investment preferences
Investment activity status
Active investor
Selected investments
Displaying 101 - 125 of 143| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Sonexa Therapeutics Inc | N/A | ||||
|
|
Sunesis Pharmaceuticals Inc | Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and he | N/A | |||
|
|
Symphony Medical Inc | Series A | ||||
|
|
Syndax Pharmaceuticals Inc | A clinical development company focused on novel oral therapies for cancer. | N/A | |||
|
|
Tandem Diabetes Care Inc | N/A | ||||
|
|
Tobira Therapeutics Inc | Dedicated to the clinical development of antiviral products | Series B | |||
|
|
Tobira Therapeutics Inc | Dedicated to the clinical development of antiviral products | Series A | |||
|
Tragara Pharmaceuticals Inc | Development of proprietary drugs for the treatment of cancer and inflammation-related disorders. | N/A | |||
|
|
Vanda Pharmaceuticals Inc | Biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders. | N/A | |||
|
|
VentiRx Pharmaceuticals Inc | N/A | ||||
|
|
Veracyte Inc | Series B | ||||
|
|
Zyga Technology Inc | Developing therapies for the treatment of back pain | N/A | |||
|
|
3F Therapeutics Inc | Developer of devices to treat heart valve disorders | N/A | |||
|
Achaogen Inc | Develops solutions to the problem of drug resistance | N/A Initial investment | |||
|
|
Achillion Pharmaceuticals Inc | Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. | N/A Initial investment | |||
|
|
Acureon Pharmaceuticals Inc | A biopharmaceutical company, develops specialty therapeutics to enhance patient outcomes in infectious diseases, transplant, and ICU areas. | N/A | |||
|
|
Adynxx Inc | A clinical stage pharmaceutical company developing a transformative technology platform addressing pain at its molecular roots. | N/A | |||
|
|
Aesthetic Sciences Corp | Focused on aesthetic medicine and incontinence | N/A | |||
|
|
Afferent Pharmaceuticals Inc | N/A | ||||
|
|
Align Technology Inc | N/A | ||||
|
|
Alimera Sciences Inc | Biopharmaceutical company. | Series B Initial investment | |||
|
|
Altair Therapeutics Inc | Developing novel therapeutics to treat human respiratory diseases. | Series B Repeat investment. | |||
|
|
Altair Therapeutics Inc | Developing novel therapeutics to treat human respiratory diseases. | Series A | |||
|
|
Applied Proteomics Inc | Developing protein biomarkers to improve healthcare and drug development. | N/A | |||
|
|
Asmacure Inc | Developer of therapeutics for the treatment of asthma. | N/A |